Erythromycin ethyl succinate
- Level
- Commodity
- Parent
- 51282300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282317This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1014KSJ86F. European Medicines Agency schedules Erythromycin ethyl succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01942MIG. Erythromycin ethyl succinate generally arises in the molecular formula C43H75NO16. The term 'erythromycin ethyl succinate' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule erythromycin ethyl succinate under HS 29415000. SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O.
Same parent
Under 51282300 · 28Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.